These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27431682)

  • 1. Thyroid hormone receptor β1 suppresses proliferation and migration by inhibiting PI3K/Akt signaling in human colorectal cancer cells.
    Zhu L; Tian G; Yang Q; De G; Zhang Z; Wang Y; Nie H; Zhang Y; Yang X; Li J
    Oncol Rep; 2016 Sep; 36(3):1419-26. PubMed ID: 27431682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. uc.338 targets p21 and cyclin D1 via PI3K/AKT pathway activation to promote cell proliferation in colorectal cancer.
    Zhang Y; Wang S; Qian W; Ji D; Wang Q; Zhang Z; Wang S; Ji B; Fu Z; Sun Y
    Oncol Rep; 2018 Aug; 40(2):1119-1128. PubMed ID: 29901203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of SPOCK1 Inhibits the Proliferation and Invasion in Colorectal Cancer Cells by Suppressing the PI3K/Akt Pathway.
    Zhao P; Guan HT; Dai ZJ; Ma YG; Liu XX; Wang XJ
    Oncol Res; 2016 Oct; 24(6):437-445. PubMed ID: 28281964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of KiSS-1 reduces colorectal cancer cell invasion by downregulating MMP-9 via blocking PI3K/Akt/NF-κB signal pathway.
    Chen S; Chen W; Zhang X; Lin S; Chen Z
    Int J Oncol; 2016 Apr; 48(4):1391-8. PubMed ID: 26847533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGM3 functions as a tumor suppressor by repressing epithelial‑to‑mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer.
    Feng Y; Ji D; Huang Y; Ji B; Zhang Y; Li J; Peng W; Zhang C; Zhang D; Sun Y; Xu Z
    Oncol Rep; 2020 Mar; 43(3):864-876. PubMed ID: 32020212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer.
    Chen JS; Huang JQ; Luo B; Dong SH; Wang RC; Jiang ZK; Xie YK; Yi W; Wen GM; Zhong JF
    Cancer Sci; 2019 Mar; 110(3):997-1011. PubMed ID: 30618098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2.
    Shan H; Zhou X; Chen C
    Mol Med Rep; 2019 Aug; 20(2):1459-1467. PubMed ID: 31173203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways.
    Wei ZJ; Tao ML; Zhang W; Han GD; Zhu ZC; Miao ZG; Li JY; Qiao ZB
    Int J Clin Exp Pathol; 2015; 8(5):4481-91. PubMed ID: 26191138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of miR-152 expression suppresses cell proliferation, survival, and migration through inhibition of AKT-ERK pathway in colorectal cancer.
    Ghazanchaei A; Mansoori B; Mohammadi A; Biglari A; Baradaran B
    J Cell Physiol; 2018 Jan; 234(1):769-776. PubMed ID: 30076720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANP32A modulates cell growth by regulating p38 and Akt activity in colorectal cancer.
    Yan W; Bai Z; Wang J; Li X; Chi B; Chen X
    Oncol Rep; 2017 Sep; 38(3):1605-1612. PubMed ID: 28731192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
    Hu F; He Z; Sun C; Rong D
    Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-296 inhibits colorectal cancer cell growth and enhances apoptosis by targeting ARRB1-mediated AKT activation.
    Zhang Z; Zhong X; Xiao Y; Chen C
    Oncol Rep; 2019 Jan; 41(1):619-629. PubMed ID: 30365090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
    Lu J; Zhang L; Zhou H; Du Z; Zhang G
    Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of FOXO6 inhibits the proliferation, invasion, and glycolysis in colorectal cancer cells.
    Li Q; Tang H; Hu F; Qin C
    J Cell Biochem; 2019 Mar; 120(3):3853-3860. PubMed ID: 30321450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
    Wang Y; Tang Q; Li M; Jiang S; Wang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
    Mu Y; Zou H; Chen B; Fan Y; Luo S
    Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.